Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study

Monoamine oxidase type B (MAO-B) inhibitors, such as selegiline and rasagiline, can be used as monotherapy or adjuvant therapy to levodopa in Parkinson’s disease (PD). Data on long-term efficacy of MAO-B inhibitors are limited with no head-to-head comparison available to date. The aim of this case–c...

Descripción completa

Detalles Bibliográficos
Autores principales: Cereda, Emanuele, Cilia, Roberto, Canesi, Margherita, Tesei, Silvana, Mariani, Claudio Bruno, Zecchinelli, Anna Lena, Pezzoli, Gianni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Original Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570795/
https://www.ncbi.nlm.nih.gov/pubmed/28550482
http://dx.doi.org/10.1007/s00415-017-8523-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5570795/
https://www.ncbi.nlm.nih.gov/pubmed/28550482
http://dx.doi.org/10.1007/s00415-017-8523-y

Ejemplares similares